Search Within

Jae Hong Park

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (7)
Groups
  1. Adult Leukemia (26)
  2. Center for Hematologic Malignancies (26)
  3. Center for Molecular Imaging and Biotechnology (26)
  4. Department of Medicine (26)
  5. GSK Faculty (26)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. David Scheinberg (12)
  2. Dan Douer (9)
  3. Martin Tallman (7)
  4. Mikhail Roshal (7)
  5. Ross Levine (7)
  6. Nancy Kernan (5)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (5)

More Years

Publications
  1. Blood (12)
  2. Journal of Clinical Oncology (3)
  3. Blood Advances (2)
  4. Cancer Research (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. Elsevier Inc. (2)
  5. Nature Publishing Group (2)
  6. Nature Research (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Treatment of patients with acute myeloid leukemia with the targeted alpha-particle nanogenerator (225)actinium-lintuzumab
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Frattini, M. G.; Maslak, P. G.; Park, J. H.; Douer, D.; Cicic, D.; Larson, S. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
    Journal Article

    Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
    Journal Article

    Saygin, C.; Kishtagari, A.; Cassaday, R. D.; Reizine, N.; Yurkiewicz, I.; Liedtke, M.; Stock, W.; Larson, R. A.; Levine, R. L.; Tallman, M. S.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
    Journal Article

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M.; Rosenblat, T.; Jurcic, J. G.; Brentjens, R. J.; Arcila, M. E.; more...
    Blood Advances (2018)

    Fulltext@MSK | Save
  • A phase 2 study of actinium-225 ((225)Ac)-lintuzumab in older patients with previously untreated acute myeloid leukemia (AML) unfit for intensive chemotherapy
    Meeting Abstract

    Finn, L. E.; Levy, M.; Orozco, J. J.; Park, J. H.; Atallah, E.; Craig, M.; Perl, A. E.; Scheinberg, D. A.; Cicic, D.; Bergonio, G. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save